News

Home / News

HealthTell in the News

China’s iCarbonX Invests in SomaLogic, Grows Medical Data Alliance

Jan 5, 2017 – GenomeWeb

The companies joining the iCarbonX Digital Life Alliance are proteomics firm SomaLogic, microbiome
therapeutics firm AOBiome, immune system diagnostics firm HealthTell, consumer health data-sharing platform PatientsLikeMe, microbiome diagnostics firm General Automation Lab Technologies (GALT), health modeling firm (and iCarbonX acquisition) Imagu, and recombinant enzyme and cosmetics firm Robustinique. […]

iCarbonX Expands Digital Life Alliance to Accelerate Development of Global Health Ecosystem

Jan 5, 2017 – icarbonx

Bob Barrett Joins HealthTell

Aug 05, 2016 – PR Newswire

Pharma’s Personalized Medicine Investment Remains Steady; Science a Major Hurdle, Tufts Report Shows

May 20, 2015 – GenomeWeb

HealthTell Expands Disease Focus to Include Infectious and Autoimmune Diseases

March 20, 2015 – Inside Tucson Business

Single Blood Drop Diagnostics Enhance Healthcare

January 30, 2015 – Medical Design Technology

HealthTell CEO Bill Colston inducted into Lawerence Livermore Entrepreneurs’ Hall Of Fame

January 15, 2015 – Lawerence Livermore National Laboratory

Movers and Shakers: Drs. Bunn and deVere White join HealthTell

January 14, 2015 – San Francisco Chronicle (SFGate)

HealthTell CEO Bill Colston shares his 2015 medtech predictions in MD&DI

January 5, 2015 – Medical Device and Diagnostic Industry (MD&DI)

What’s in store for the medtech industry this year? “Tools that significantly improve the accuracy and allow longer read lengths for next-generation sequencing systems will become available in 2015. These tools will provide researchers with the ability to pioneer completely new diagnostic applications that are currently unattainable and hasten next-generation” […]

5 Bay Area life sciences companies looking to win big in 2015

January 5, 2015 – San Francisco Business Times

Ron Leuty, Reporter (San Francisco Business Times) – Selecting the best Bay Area life sciences CEOs three years ago was a difficult task as the industry was only starting to slither out of the muck of the Great Recession. Picking five Bay Area companies to watch this year is just as difficult, if only because I’m limiting myself to five. […]

Bay Area startups Theranos, HealthTell are out for blood

December 26, 2014 – San Francisco Chronicle

Stephanie Lee (San Francisco Chronicle) – …Using technology spun out of Arizona State University, HealthTell of San Ramon wants to use a bit of blood to detect more than 30 early-stage diseases […]

(Subscription Required)

(See Also – SF GATE http://tinyurl.com/lsdsp5e)

HealthTell among select few whose one drop of blood test is going a long way to diagnose disease.

December 4, 2014 – G2 Intelligence | Diagnostic Testing & Emerging Technologies

Lori Solomon, Editor (G2 Intelligence) – A single drop of blood also holds an immunosignature that can provide clues about the body’s disease states. This approach avoids the need to measure the pathogen directly and capitalizes on the body’s own immune-related amplification processes to ensure sensitive results, while using miniscule sample sizes […]

(Subscription Required)

West Coast Biotech Roundup: Amgen, Ariosa, Avanir, Audentes & More

December 4, 2014 – Xconomy

Alex Lash (Xconomy) – Where is biotech innovation? All over, we would contend, but according to The Scientist magazine […]

HealthTell Wins $225K SBIR Grant for Brain Cancer Dx Work

December 2, 2014 – GenomeWeb

NEW YORK (GenomeWeb) – HealthTell said today that it has received a $225,000 SBIR grant from the National Institutes of Health. The funds will support work to evaluate the effectiveness of the company’s immunosignature technology in the diagnosis of brain cancer, and glioblastoma multiforme, specifically. […]

Test Detects Brain Cancer in a Drop of Blood

December 2, 2014 – Medical Device Technology Magazine (MDTMag)

HealthTell, an early stage Life Sciences company, today announced it has been awarded a $225,000 SBIR grant (1R43CA183360-01) from the National Institutes of Health (NIH) to evaluate the performance of the company’s proprietary Immunosignature Technology in accurately diagnosing brain cancer.  […]

HealthTell tech measures individual immune response to diseases

November 25, 2014 – Medical Device Daily™

Amanda Pedersen, Senior Staff Writer (Medical Device Daily) – One of the biggest challenges in modern medicine is the ability to detect diseases early when they are the most treatable. Generally this requires complex, expensive monitoring systems capable of detecting small changes in cancer cells, viruses, or other pathogens in the bloodstream, but one early-stage company has developed a technology platform that puts a unique spin on diagnosing diseases. […]

HealthTell Begins Feasibility Studies for First Immunosignaturing Dx

October 31, 2014 – GenomeWeb

NEW YORK (GenomeWeb) – Having refined its platform and manufacturing process, diagnostics firm HealthTell has now moved into clinical feasibility studies with the aim of launching its first test by the end of next year, CEO Bill Colston told ProteoMonitor this week. […]

HealthTell part of $1.5 billion dollar impact on Arizona Economy

 August 26, 2014 – ASU News

Arizona State University’s Biodesign Institute has made an economic impact of $1.5 billion in its first decade of operation, according to a study by the Seidman Research Institute at ASU’s W. P. Carey School of Business. […]

HealthTell Named One of “Spin-Outs to Watch in 2014″

 January 12, 2014 – Global University Venturing

Gregg Bayes-Brown, (Global University Venturing) – Many of the companies we report on at GUV could potentially have wide-reaching impacts as they grow. However, some stand out more […]